What's new

Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 22, Status: Authorised

Feb 10, 2025 - 17:52
 0
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 22, Status: Authorised
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 22, Status: Authorised
Read More

Tags:

Previous Article

Novartis debuts €40M viral vector plant in Slovenia, part of €3.5B investment pu...

Next Article

Leading Philippines EV Company Energizes More Charging Stations, Launches Member...

Related Posts

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Minutes - HMA-EMA joint Big Data Steering Group telecon...

Feb 17, 2025  0

Human medicines European public assessment report (EPAR): Evkeeza, evinacumab, Date of authorisation: 17/06/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0